Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vaxart Inc VXRT

Healthcare Biotechnology
Vaxart, Inc. is a clinical-stage biotechnology company that is primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) proprietary oral vaccine platform. Its vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Its... see more

Recent & Breaking News (NDAQ:VXRT)

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against American Electric Power, OneSpan, Qutoutiao, and Vaxart and Encourages Investors to Contact the Firm

GlobeNewswire September 2, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Vaxart (VXRT) Investors of Securities Fraud Class Action, Encourages Investors with Significant Losses to Contact its Attorneys

Newsfile September 2, 2020

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Vaxart, Inc. (VXRT)

Business Wire September 2, 2020

VXRT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 23, 2020 in the Class Action Filed on Behalf of Vaxart, Inc. Limited Shareholders

Newsfile September 1, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Vaxart (VXRT) Investors of Filed Securities Fraud Class Action, Encourages Investors with Significant Losses to Contact its Attorneys

Newsfile September 1, 2020

FINAL DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vaxart, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

ACCESSWIRE IA September 1, 2020

VXRT Investor Update: Bronstein, Gewirtz & Grossman, LLC Notifies Vaxart, Inc. Investors of Class Action and Lead Plaintiff Deadline: October 23, 2020

Newsfile September 1, 2020

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Vaxart, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 23, 2020 - VXRT

Newsfile August 31, 2020

INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vaxart, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

ACCESSWIRE IA August 31, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Vaxart (VXRT) Investors to Securities Fraud Class Action, Encourages Investors with Losses to Contact its Attorneys Now

GlobeNewswire August 31, 2020

VXRT EQUITY ALERT: ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Announces Filing of Securities Class Action Lawsuit Against Vaxart, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm - VXRT

GlobeNewswire August 31, 2020

DEADLINE ALERT for OSPN, VXRT, PLAN, and BLNK: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

GlobeNewswire August 31, 2020

VXRT Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Vaxart, Inc. Investors of Class Action and Lead Plaintiff Deadline: October 23, 2020

ACCESSWIRE IA August 31, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vaxart, Inc. -VXRT

GlobeNewswire August 29, 2020

SHAREHOLDER ACTION DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vaxart, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

ACCESSWIRE IA August 28, 2020

VXRT NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Securities Class Action Lawsuit Against Vaxart, Inc. Seeking Recovery of Investor Losses - VXRT

ACCESSWIRE IA August 28, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Vaxart (VXRT) Investors: Securities Fraud Class Action Filed, Investors with Losses Encouraged to Contact its Attorneys Now

Newsfile August 28, 2020

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Vaxart, Inc. (VXRT)

Business Wire August 28, 2020

VXRT Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Vaxart, Inc. Investors of Class Action and Lead Plaintiff Deadline: October 23, 2020

PR Newswire August 28, 2020

INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vaxart, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

ACCESSWIRE IA August 27, 2020